Sanofi-Aventis (Euronext Paris: SAN)
174 avenue de France
75013 Paris, France (Map) Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
Primary US Office:
Subscribers Only http://www.sanofi-aventis.com
75013 Paris, France (Map) Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
Primary US Office:
Subscribers Only http://www.sanofi-aventis.com
Basic Financial Information (SAN)
- Company Type
- Public (Euronext Paris: SAN; NYSE: SNY [ADR])
- Fiscal Year-End
- December
- Financial Filings
- US SEC
- Investor Relations
- Company Web Site
Annual Income Statements (SAN)
All amounts in millions of British Pounds except share amounts
| Year | Revenue | Gross Profit | Operating Income | Total Net Income | Diluted EPS (Net Income) |
|---|---|---|---|---|---|
| Dec 07 | 21,539.6 | 15,956.1 | 4,359.2 | 8,369.0 | 1.95 |
| Dec 06 | 19,872.1 | 14,761.4 | 2,883.5 | 5,326.1 | 2.00 |
| Dec 05 | 19,624.2 | 14,416.2 | 2,457.8 | 2,608.1 | 1.13 |
- Income Statement, Balance Sheet, and Cash Flow
Quarterly Income Statements (SAN)
All amounts in millions of British Pounds except share amounts
| Year | Revenue | Gross Profit | Operating Income | Total Net Income | Diluted EPS (Net Income) |
|---|
- Income Statement, Balance Sheet, and Cash Flow
Stock Quote & Chart (F)
| Date & Time | 12/02/08 16:01:34 EST |
|---|---|
| Price | $27.52 NYSE |
| Change |
 0.86 |
| %Change |
3.23
%
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Comparison To Industry & Market (SAN)
| Valuation | Company | Industry1 | Market2 |
|---|---|---|---|
| Price/Sales Ratio | 0.14 | 2.19 | 0.94 |
| Price/Earnings Ratio | 7.07 | 10.78 | 10.50 |
| Price/Book Ratio | 0.10 | 1.67 | 0.89 |
| Price/Cash Flow Ratio | 0.59 | 8.97 | 5.93 |
- 1Industry: Chemicals And Allied Products
- 2Market: Public companies trading on the NYSE, AMEX, and NASDAQ
- Side-by-side comparison of Sanofi-Aventis and its top 3 competitors
Top Competitors (SAN)
| Sanofi-Aventis | Eli Lilly | Merck | Pfizer | |
|---|---|---|---|---|
| Annual Sales | 27,979.5 | 12,119.2 | 15,738.2 | 31,491.1 |
| Employees | 99,495 | 40,600 | 59,800 | 86,600 |
| Market Cap (£ mil.) | 0.0 | 23,012.4 | 34,170.4 | 67,012.0 |
- Side-by-side comparisons of profitability, operations, and per share data